SCHEMBL6642674

SCHEMBL6642674

O=C(O)C1=CC(c2ccccc2)CCC1S(=O)(=O)Nc1ccc(F)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR4 O00206 5/20 0.52
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ACLY P53396 1/20 0.35
MRGPRX1 Q96LB2 1/20 0.35
PTK2B Q14289 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NAMPT P43490 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
HPGD P15428 1/20 0.34
FABP4 P15090 2/20 0.34
FABP3 P05413 1/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
NPY1R P25929 1/20 0.34
NPY2R P49146 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PYGL P06737 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6644470 0.89 TLR4 (0.40) TLR4NPC1RAB9AACLYMRGPRX1
SCHEMBL872571 0.86 TLR4 (0.70) TLR4KMT2AMRGPRX1LMNA
SCHEMBL27592449 0.81 TLR4 (0.72) TLR4KMT2ANPC1RAB9AACLY
SCHEMBL872269 0.79 TLR4 (0.73) TLR4KMT2ANPC1RAB9AACLY
SCHEMBL722368 0.79 TLR4 (0.73) TLR4KMT2ANPC1RAB9AACLY
SCHEMBL3690868 0.79 TLR4 (0.73) TLR4KMT2ANPC1RAB9AACLY
SCHEMBL27592234 0.78 TLR4 (0.73) TLR4KMT2ANPC1RAB9AACLY
SCHEMBL27592447 0.77 TLR4 (0.55) TLR4KMT2ANPC1RAB9AACLY
SCHEMBL871177 0.76 TLR4 (0.57) TLR4MRGPRX1TP53MAPT
SCHEMBL1865788 0.74 TLR4 (0.50) TLR4KMT2ANPC1RAB9AACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101212986-B Stable emulsified composition TAKEDA PHARMACEUTICAL 2015-01-14 CN disclosed
CN-102821763-A Compound for inhibiting peripheral nerve disorder induced by anticancer agent TAKEDA PHARMACEUTICAL 2012-12-12 CN disclosed
CN-102670503-A Stable emulsion composition TAKEDA PHARMACEUTICAL 2012-09-19 CN disclosed
EP-1420783-A1 STABLE EMULSION COMPOSITION Takeda Chemical Industries, Ltd. (JP) 2004-05-26 EP disclosed
WO-2003013513-A1 STABLE EMULSION COMPOSITION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-02-20 WO disclosed